Unique Paraffin-reactive Anti-human Cd19 Monoclonal
Apr 01 2006 Read 1873 Times
Serotec Ltd. have launched the only commercially available anti-human CD19 monoclonal antibody suitable for paraffin-reactive immunohistological studies.
CD19 is a 95 kDa member of the immunoglobulin superfamily. It is a characteristic B cell marker expressed from the early stages of commitment to B cell lineage, and on all mature B cells. It is absent from plasma cells.
CD19 has been widely used in flow cytometry as a specific marker of B cell lineage for leukaemias and lymphomas, and this antibody will now make immunohistological assessment of this important lineage marker possible in routinely fixed tissues.
MCA2454 is a multi-purpose antibody that also works well in immunoprecipitation, Western blotting and flow cytometry following cell surface permeabilisation.
CD19 is a 95 kDa member of the immunoglobulin superfamily. It is a characteristic B cell marker expressed from the early stages of commitment to B cell lineage, and on all mature B cells. It is absent from plasma cells.
CD19 has been widely used in flow cytometry as a specific marker of B cell lineage for leukaemias and lymphomas, and this antibody will now make immunohistological assessment of this important lineage marker possible in routinely fixed tissues.
MCA2454 is a multi-purpose antibody that also works well in immunoprecipitation, Western blotting and flow cytometry following cell surface permeabilisation.
Digital Edition
Lab Asia December 2020
December 2020
In This Edition Articles - The Movement Towards More Comprehensive Testing of Mycotoxins in Cannabis - Addressing proper HACCP implementation - Micropatterning: The art of micro-controlling...
View all digital editions
Events
Jan 23 2021 Digital Event
Jan 26 2021 Virtual event
Filtech - POSTPONED. NEW DATES TBC
Feb 23 2021 Cologne, Germany
Feb 28 2021 Virtual event
Mar 03 2021 Guanghzou, China
Reader comments
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.